As of 2026-02-07, the Relative Valuation of Pulmonx Corp (LUNG) is (28.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.50 USD, the upside of Pulmonx Corp based on Relative Valuation is -1998.6%.
The range of the Relative Valuation is (30.57) - (30.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.2x - 29.5x | 25.7x |
| Forward P/E multiples | 14.3x - 22.2x | 15.7x |
| Fair Price | (30.57) - (30.52) | (28.48) |
| Upside | -2138.1% - -2134.4% | -1998.6% |
| Date | P/E |
| 2026-02-03 | -1.13 |
| 2026-02-02 | -1.18 |
| 2026-01-30 | -1.19 |
| 2026-01-29 | -1.25 |
| 2026-01-28 | -1.28 |
| 2026-01-27 | -1.27 |
| 2026-01-26 | -1.30 |
| 2026-01-23 | -1.34 |
| 2026-01-22 | -1.39 |
| 2026-01-21 | -1.35 |
| 2026-01-20 | -1.29 |
| 2026-01-16 | -1.29 |
| 2026-01-15 | -1.33 |
| 2026-01-14 | -1.45 |
| 2026-01-13 | -1.42 |
| 2026-01-12 | -1.45 |
| 2026-01-09 | -1.48 |
| 2026-01-08 | -1.53 |
| 2026-01-07 | -1.61 |
| 2026-01-06 | -1.69 |
| 2026-01-05 | -1.63 |
| 2026-01-02 | -1.67 |
| 2025-12-31 | -1.61 |
| 2025-12-30 | -1.66 |
| 2025-12-29 | -1.62 |
| 2025-12-26 | -1.61 |
| 2025-12-24 | -1.66 |
| 2025-12-23 | -1.61 |
| 2025-12-22 | -1.73 |
| 2025-12-19 | -1.89 |
| 2025-12-18 | -1.83 |
| 2025-12-17 | -1.85 |
| 2025-12-16 | -1.80 |
| 2025-12-15 | -1.85 |
| 2025-12-12 | -1.84 |
| 2025-12-11 | -1.82 |
| 2025-12-10 | -1.79 |
| 2025-12-09 | -1.69 |
| 2025-12-08 | -1.48 |
| 2025-12-05 | -1.46 |
| 2025-12-04 | -1.56 |
| 2025-12-03 | -1.37 |
| 2025-12-02 | -1.27 |
| 2025-12-01 | -1.28 |
| 2025-11-28 | -1.18 |
| 2025-11-26 | -1.18 |
| 2025-11-25 | -1.24 |
| 2025-11-24 | -1.13 |
| 2025-11-21 | -1.05 |
| 2025-11-20 | -0.95 |